{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"Research Square"}],"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T15:25:39Z","timestamp":1786116339783,"version":"build-2736575974"},"posted":{"date-parts":[[2026,8,6]]},"group-title":"In Review","reference-count":82,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T00:00:00Z","timestamp":1785974400000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2026,6,2]]},"abstract":"<title>Abstract<\/title>\n                <p>Young breast cancer patients have increased risk for liver metastasis (BCLM), implicating age-dependent organotropism. To explore potential risk factors and mechanisms of BCLM, we unbiasedly recruited 47 patients diagnosed with BCLM at a tertiary medical center, collected clinicopathologic data of the primary breast cancers, and obtained paired BCLM lesion tissue. Compared to the overall breast cancer patient population, our BCLM cohort was enriched ~4 fold for young patients (YOBC) and ~5 fold for patients diagnosed within 10 years of recent childbirth. The majority of primary breast cancer diagnoses were luminal A, low-grade and early-stage disease, clinical attributes classically associated with good prognosis. Most BCLM lesions were also ER-positive, and the dominant breast cancer growth pattern was replacement. Immunohistology staining infers utilization of existing liver sinusoids, consistent with a passive mechanism of metastatic invasion. In sum, these data suggest that the liver readily supports metastatic establishment of early-stage, luminal A breast cancer cells. These data also support a growing body of literature linking postpartum liver biology to increased risk for BCLM, providing potential insight into the observed age-dependent organotropism of BCLM. Improved understanding of reproductive risk factors for BCLM may improve patient risk stratification and outcomes overall.<\/p>","DOI":"10.21203\/rs.3.rs-9903557\/v1","type":"posted-content","created":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T08:57:53Z","timestamp":1786006673000},"source":"Crossref","is-referenced-by-count":0,"title":["Breast Cancer Liver Metastasis: Primary tumor predictors and histopathologic characteristics of metastatic lesions"],"prefix":"10.21203","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4244-987X","authenticated-orcid":false,"given":"Pepper","family":"Schedin","sequence":"first","affiliation":[{"name":"Oregon Health and Science University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-4208-9279","authenticated-orcid":false,"given":"Hatun Duran","family":"Cete","sequence":"additional","affiliation":[{"name":"Oregon Health & Science University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jackie","family":"Phipps","sequence":"additional","affiliation":[{"name":"Oregon Health & Science University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7912-6084","authenticated-orcid":false,"given":"Alexandra","family":"Bartlett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Ozaki","sequence":"additional","affiliation":[{"name":"Oregon Health & Science University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Skye","family":"Mayo","sequence":"additional","affiliation":[{"name":"Oregon Health & Science University"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","author":"Society AC","year":"2026","unstructured":"Society, A.C.: January 13, Survival Rates for Breast Cancer, (2026). https:\/\/www.cancer.org\/cancer\/types\/breast-cancer\/understanding-a-breast-cancer-diagnosis\/breast-cancer-survival-rates.html"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"477","DOI":"10.3322\/caac.21863","article-title":"Breast cancer statistics 2024","volume":"74","author":"Giaquinto AN","year":"2024","unstructured":"Giaquinto, A.N., et al.: Breast cancer statistics 2024. Cancer J. Clin. 74, 477\u2013495 (2024). https:\/\/doi.org\/https:\/\/doi.org\/10.3322\/caac.21863","journal-title":"Cancer J. Clin."},{"key":"ref3","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1007\/s10549-016-3984-8","article-title":"Young adult breast cancer patients have a poor prognosis independent of prognostic clinicopathological factors: a study from the Japanese Breast Cancer Registry","volume":"160","author":"Kataoka A","year":"2016","unstructured":"Kataoka, A., et al.: Young adult breast cancer patients have a poor prognosis independent of prognostic clinicopathological factors: a study from the Japanese Breast Cancer Registry. Breast Cancer Res. Treat. 160, 163\u2013172 (2016). https:\/\/doi.org\/10.1007\/s10549-016-3984-8","journal-title":"Breast Cancer Res. Treat."},{"key":"ref4","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1038\/nrclinonc.2012.102","article-title":"Breast cancer in young women","volume":"9","author":"Narod SA","year":"2012","unstructured":"Narod, S.A.: Breast cancer in young women. Nat. Rev. Clin. Oncol. 9, 460\u2013470 (2012). https:\/\/doi.org\/10.1038\/nrclinonc.2012.102","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"ref5","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1001\/jama.2013.776","article-title":"Incidence of Breast Cancer With Distant Involvement Among Women in the United States, 1976 to 2009","volume":"309","author":"Johnson RH","year":"2013","unstructured":"Johnson, R.H., Chien, F.L., Bleyer, A.: Incidence of Breast Cancer With Distant Involvement Among Women in the United States, 1976 to 2009. JAMA. 309, 800\u2013805 (2013). https:\/\/doi.org\/10.1001\/jama.2013.776","journal-title":"JAMA"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1038\/s41523-025-00822-y","article-title":"The association between young age at metastatic breast cancer diagnosis and overall survival in the EMBRACE study","volume":"11","author":"Brantley KD","year":"2025","unstructured":"Brantley, K.D., et al.: The association between young age at metastatic breast cancer diagnosis and overall survival in the EMBRACE study. npj Breast Cancer. 11, 96 (2025). https:\/\/doi.org\/10.1038\/s41523-025-00822-y","journal-title":"npj Breast Cancer"},{"key":"ref7","volume-title":"Breast Cancer Facts & Figs. 2024\u20132025","author":"Society AC","year":"2024","unstructured":"Society, A.C.: Breast Cancer Facts & Figs. 2024\u20132025. American Cancer Society, Atlanta (2024)"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"e2353331","DOI":"10.1001\/jamanetworkopen.2023.53331","article-title":"Breast Cancer Incidence Among US Women Aged 20 to 49 Years by Race, Stage, and Hormone Receptor Status","volume":"7","author":"Xu S","year":"2024","unstructured":"Xu, S., Murtagh, S., Han, Y., Wan, F., Toriola, A.T.: Breast Cancer Incidence Among US Women Aged 20 to 49 Years by Race, Stage, and Hormone Receptor Status. JAMA Netw. Open. 7, e2353331\u2013e2353331 (2024). https:\/\/doi.org\/10.1001\/jamanetworkopen.2023.53331","journal-title":"JAMA Netw. Open."},{"key":"ref9","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/j.jamcollsurg.2008.12.001","article-title":"Elevated Breast Cancer Mortality in Women Younger than Age 40 Years Compared with Older Women Is Attributed to Poorer Survival in Early-Stage Disease","volume":"208","author":"Gnerlich JL","year":"2009","unstructured":"Gnerlich, J.L., et al.: Elevated Breast Cancer Mortality in Women Younger than Age 40 Years Compared with Older Women Is Attributed to Poorer Survival in Early-Stage Disease. J. Am. Coll. Surg. 208, 341\u2013347 (2009). https:\/\/doi.org\/https:\/\/doi.org\/10.1016\/j.jamcollsurg.2008.12.001","journal-title":"J. Am. Coll. Surg."},{"key":"ref10","doi-asserted-by":"publisher","first-page":"S176","DOI":"10.1016\/j.breast.2013.07.034","article-title":"Management of breast cancer in very young women","volume":"22","author":"Freedman RA","year":"2013","unstructured":"Freedman, R.A., Partridge, A.H.: Management of breast cancer in very young women. Breast. 22, S176\u2013S179 (2013). https:\/\/doi.org\/https:\/\/doi.org\/ 10.1016\/j.breast.2013.07.034","journal-title":"Breast"},{"key":"ref11","author":"Partridge AH","year":"2016","unstructured":"Partridge, A.H.: Subtype-Dependent Relationship Between Young Age at Diagnosis and Breast Cancer Survival. (2016)"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1016\/j.ejca.2017.07.044","article-title":"Breast cancer in young women and prognosis: How important are proliferation markers?","volume":"84","author":"Fredholm H","year":"2017","unstructured":"Fredholm, H., et al.: Breast cancer in young women and prognosis: How important are proliferation markers? Eur. J. Cancer. 84, 278\u2013289 (2017). https:\/\/doi.org\/https:\/\/doi.org\/ 10.1016\/j.ejca.2017.07.044","journal-title":"Eur. J. Cancer"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1634\/theoncologist.2011-0469","article-title":"The effect of age on delay in diagnosis and stage of breast cancer","volume":"17","author":"Partridge AH","year":"2012","unstructured":"Partridge, A.H., et al.: The effect of age on delay in diagnosis and stage of breast cancer. Oncologist. 17, 775\u2013782 (2012)","journal-title":"Oncologist"},{"key":"ref14","author":"Mc Shane N","year":"2024","unstructured":"Mc Shane, N.: Hormone Receptor Positive Breast Cancer in Young Women: A Review. (2024)"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1093\/jncics\/pkz040","article-title":"Incidence and Survival Among Young Women With Stage I\u2013III Breast Cancer: SEER 2000\u20132015","volume":"3","author":"Thomas A","year":"2019","unstructured":"Thomas, A., et al.: Incidence and Survival Among Young Women With Stage I\u2013III Breast Cancer: SEER 2000\u20132015. JNCI Cancer Spectr. 3 (2019). https:\/\/doi.org\/10.1093\/jncics\/pkz040","journal-title":"JNCI Cancer Spectr."},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctrv.2024.102804","article-title":"Hormone receptor-positive early breast cancer in young women: A comprehensive review","volume":"129","author":"Walbaum B","year":"2024","unstructured":"Walbaum, B., et al.: Hormone receptor-positive early breast cancer in young women: A comprehensive review. Cancer Treat. Rev. 129 (2024). https:\/\/doi.org\/10.1016\/j.ctrv.2024.102804","journal-title":"Cancer Treat. Rev."},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2022.36763","author":"Zhang Z","year":"2022","unstructured":"Zhang, Z., et al.: Young-Onset Breast Cancer Outcomes by Time Since Recent Childbirth in Utah. JAMA Netw Open 5, e2236763 (2022). https:\/\/doi.org\/10.1001\/jamanetworkopen.2022.36763"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1007\/s10549-016-3989-3","article-title":"The prognosis of women diagnosed with breast cancer before, during and after pregnancy: a meta-analysis","volume":"160","author":"Hartman EK","year":"2016","unstructured":"Hartman, E.K., Eslick, G.D.: The prognosis of women diagnosed with breast cancer before, during and after pregnancy: a meta-analysis. Breast Cancer Res. Treat. 160, 347\u2013360 (2016). https:\/\/doi.org\/10.1007\/s10549-016-3989-3","journal-title":"Breast Cancer Res. Treat."},{"key":"ref19","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.ejca.2022.03.014","article-title":"Overall survival is the lowest among young women with postpartum breast cancer","volume":"168","author":"Shagisultanova E","year":"2022","unstructured":"Shagisultanova, E., et al.: Overall survival is the lowest among young women with postpartum breast cancer. Eur. J. Cancer. 168, 119\u2013127 (2022). https:\/\/doi.org\/10.1016\/j.ejca.2022.03.014","journal-title":"Eur. J. Cancer"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1158\/2159-8290.Cd-16-0822","article-title":"The Rodent Liver Undergoes Weaning-Induced Involution and Supports Breast Cancer Metastasis","volume":"7","author":"Goddard ET","year":"2017","unstructured":"Goddard, E.T., et al.: The Rodent Liver Undergoes Weaning-Induced Involution and Supports Breast Cancer Metastasis. Cancer Discov. 7, 177\u2013187 (2017). https:\/\/doi.org\/10.1158\/2159-8290.Cd-16-0822","journal-title":"Cancer Discov"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.ejca.2021.06.009","article-title":"Breast cancer diagnosed in the post-weaning period is indicative for a poor outcome","volume":"155","author":"Lefr\u00e8re H","year":"2021","unstructured":"Lefr\u00e8re, H., et al.: Breast cancer diagnosed in the post-weaning period is indicative for a poor outcome. Eur. J. Cancer. 155, 13\u201324 (2021). https:\/\/doi.org\/https:\/\/doi. org\/10.1016\/j.ejca.2021.06.009","journal-title":"Eur. J. Cancer"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1186\/s12967-018-1733-y","article-title":"Implementing a comprehensive translational oncology platform: from molecular testing to actionability","volume":"16","author":"Mitri ZI","year":"2018","unstructured":"Mitri, Z.I., et al.: Implementing a comprehensive translational oncology platform: from molecular testing to actionability. J. Transl Med. 16, 358 (2018). https:\/\/doi.org\/10.1186\/s12967-018-1733-y","journal-title":"J. Transl Med."},{"key":"ref23","unstructured":"(OWH): O. o. W. s. H. Menopause basics, (2025). https:\/\/womenshealth.gov\/menopause\/menopause-basics"},{"key":"ref24","volume-title":"Carolina Aragao. Demographic and Economic Characteristics of Adults 50 and Older Without Children","author":"Rachel Minkin JMH","year":"2024","unstructured":"Rachel Minkin, J.M.H.: Carolina Aragao. Demographic and Economic Characteristics of Adults 50 and Older Without Children. Pew Research Center, Washington, DC (2024)"},{"key":"ref25","first-page":"1","article-title":"Fertility of Men and Women Aged 15\u201349 in the United States: National Survey of Family Growth,2015\u20132019","author":"Martinez GM","year":"2023","unstructured":"Martinez, G.M., Daniels, K.: Fertility of Men and Women Aged 15\u201349 in the United States: National Survey of Family Growth,2015\u20132019. Natl. Health Stat. Rep., 1\u201322 (2023)","journal-title":"Natl. Health Stat. Rep."},{"key":"ref26","author":"Bureau USC","year":"2024","unstructured":"Bureau, U.S.C.: United States Population by Age and SexUnited States Population by Age and Sex, < (2024). https:\/\/www.census.gov"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1200\/jco.19.02309","article-title":"Estrogen and Progesterone Receptor Testing in Breast Cancer: ASCO\/CAP Guideline Update","volume":"38","author":"Allison KH","year":"2020","unstructured":"Allison, K.H., et al.: Estrogen and Progesterone Receptor Testing in Breast Cancer: ASCO\/CAP Guideline Update. J. Clin. Oncol. 38, 1346\u20131366 (2020). https:\/\/doi.org\/10.1200\/jco.19.02309","journal-title":"J. Clin. Oncol."},{"key":"ref28","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1186\/bcr2607","article-title":"Breast cancer prognostic classification in the molecular era: the role of histological grade","volume":"12","author":"Rakha EA","year":"2010","unstructured":"Rakha, E.A., et al.: Breast cancer prognostic classification in the molecular era: the role of histological grade. Breast Cancer Res. 12, 207 (2010). https:\/\/doi.org\/10.1186\/bcr2607","journal-title":"Breast Cancer Res."},{"key":"ref29","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1038\/s41416-022-01859-7","article-title":"Histopathological growth patterns of liver metastasis: updated consensus guidelines for pattern scoring, perspectives and recent mechanistic insights","volume":"127","author":"Latacz E","year":"2022","unstructured":"Latacz, E., et al.: Histopathological growth patterns of liver metastasis: updated consensus guidelines for pattern scoring, perspectives and recent mechanistic insights. Br. J. Cancer. 127, 988\u20131013 (2022). https:\/\/doi.org\/10.1038\/s41416-022-01859-7","journal-title":"Br. J. Cancer"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.1038\/bjc.2017.334","article-title":"International consensus guidelines for scoring the histopathological growth patterns of liver metastasis","volume":"117","author":"Dam P-J","year":"2017","unstructured":"van Dam, P.-J., et al.: International consensus guidelines for scoring the histopathological growth patterns of liver metastasis. Br. J. Cancer. 117, 1427\u20131441 (2017). https:\/\/doi.org\/10.1038\/bjc.2017.334","journal-title":"Br. J. Cancer"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1038\/s41523-023-00602-6","article-title":"Histopathological growth patterns and tumor-infiltrating lymphocytes in breast cancer liver metastases","volume":"9","author":"Leduc S","year":"2023","unstructured":"Leduc, S., et al.: Histopathological growth patterns and tumor-infiltrating lymphocytes in breast cancer liver metastases. npj Breast Cancer. 9, 100 (2023). https:\/\/doi.org\/10.1038\/s41523-023-00602-6","journal-title":"npj Breast Cancer"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1007\/s10549-013-2560-8","article-title":"Ki-67 is a prognostic parameter in breast cancer patients: results of a large population-based cohort of a cancer registry","volume":"139","author":"Inwald EC","year":"2013","unstructured":"Inwald, E.C., et al.: Ki-67 is a prognostic parameter in breast cancer patients: results of a large population-based cohort of a cancer registry. Breast Cancer Res. Treat. 139, 539\u2013552 (2013). https:\/\/doi.org\/10.1007\/s10549-013-2560-8","journal-title":"Breast Cancer Res. Treat."},{"key":"ref33","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/s41523-020-00196-3","article-title":"Characterization of weaning-induced breast involution in women: implications for young women\u2019s breast cancer","volume":"6","author":"Jindal S","year":"2020","unstructured":"Jindal, S., Narasimhan, J., Borges, V.F., Schedin, P.: Characterization of weaning-induced breast involution in women: implications for young women\u2019s breast cancer. npj Breast Cancer. 6, 55 (2020). https:\/\/doi.org\/10.1038\/s41523-020-00196-3","journal-title":"npj Breast Cancer"},{"key":"ref34","author":"Surveillance E","unstructured":"Surveillance, E.: and End Results Preogram. Cancer Stat Facts: Female Breast Cancer."},{"key":"ref35","doi-asserted-by":"publisher","first-page":"e1027","DOI":"10.1016\/s2214-109x(20)30215-1","article-title":"Global burden and trends in premenopausal and postmenopausal breast cancer: a population-based study","volume":"8","author":"Heer E","year":"2020","unstructured":"Heer, E., et al.: Global burden and trends in premenopausal and postmenopausal breast cancer: a population-based study. Lancet Glob Health. 8, e1027\u2013e1037 (2020). https:\/\/doi.org\/10.1016\/s2214-109x(20)30215-1","journal-title":"Lancet Glob Health"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1007\/s10549-013-2437-x","article-title":"Postpartum diagnosis demonstrates a high risk for metastasis and merits an expanded definition of pregnancy-associated breast cancer","volume":"138","author":"Callihan EB","year":"2013","unstructured":"Callihan, E.B., et al.: Postpartum diagnosis demonstrates a high risk for metastasis and merits an expanded definition of pregnancy-associated breast cancer. Breast Cancer Res. Treat. 138, 549\u2013559 (2013). https:\/\/doi.org\/10.1007\/s10549-013-2437-x","journal-title":"Breast Cancer Res. Treat."},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2024.7421","author":"Zhang Z","year":"2024","unstructured":"Zhang, Z., et al.: Postpartum Breast Cancer and Survival in Women With Germline BRCA Pathogenic Variants. JAMA Netw Open 7, e247421 (2024). https:\/\/doi.org\/10.1001\/jamanetworkopen.2024.7421"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1309\/ajcpyo5fsv3upexs","article-title":"Breast Cancer Subtypes Predispose the Site of Distant Metastases","volume":"143","author":"Soni A","year":"2015","unstructured":"Soni, A., et al.: Breast Cancer Subtypes Predispose the Site of Distant Metastases. Am. J. Clin. Pathol. 143, 471\u2013478 (2015). https:\/\/doi.org\/10.1309\/ajcpyo5fsv3upexs","journal-title":"Am. J. Clin. Pathol."},{"key":"ref39","doi-asserted-by":"publisher","first-page":"45411","DOI":"10.1038\/srep45411","article-title":"Impact of molecular subtypes on metastatic breast cancer patients: a SEER population-based study","volume":"7","author":"Gong Y","year":"2017","unstructured":"Gong, Y., Liu, Y.-R., Ji, P., Hu, X., Shao, Z.-M.: Impact of molecular subtypes on metastatic breast cancer patients: a SEER population-based study. Sci. Rep. 7, 45411 (2017). https:\/\/doi.org\/10.1038\/srep45411","journal-title":"Sci. Rep."},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.872862","article-title":"Metastasis patterns and prognosis in young breast cancer patients: A SEER database analysis","volume":"12\u20132022","author":"Zhang W","year":"2022","unstructured":"Zhang, W., et al.: Metastasis patterns and prognosis in young breast cancer patients: A SEER database analysis. Front. Oncol. 12\u20132022 (2022). https:\/\/doi.org\/10.3389\/fonc.2022.872862","journal-title":"Front. Oncol."},{"key":"ref41","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1186\/s12885-021-07968-5","article-title":"Risk and prognostic factors of breast cancer with liver metastases","volume":"21","author":"Ji L","year":"2021","unstructured":"Ji, L., et al.: Risk and prognostic factors of breast cancer with liver metastases. BMC Cancer. 21, 238 (2021). https:\/\/doi.org\/10.1186\/s12885-021-07968-5","journal-title":"BMC Cancer"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"2499","DOI":"10.1038\/s41379-020-0615-z","article-title":"Receptor conversion in metastatic breast cancer: analysis of 390 cases from a single institution","volume":"33","author":"Chen R","year":"2020","unstructured":"Chen, R., Qarmali, M., Siegal, G.P., Wei, S.: Receptor conversion in metastatic breast cancer: analysis of 390 cases from a single institution. Mod. Pathol. 33, 2499\u20132506 (2020). https:\/\/doi.org\/10.1038\/s41379-020-0615-z","journal-title":"Mod. Pathol."},{"key":"ref43","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1093\/jnci\/djx273","article-title":"Receptor Conversion in Distant Breast Cancer Metastases: A Systematic Review and Meta-analysis","volume":"110","author":"Schrijver W","year":"2018","unstructured":"Schrijver, W., et al.: Receptor Conversion in Distant Breast Cancer Metastases: A Systematic Review and Meta-analysis. J. Natl. Cancer Inst. 110, 568\u2013580 (2018). https:\/\/doi.org\/10.1093\/jnci\/djx273","journal-title":"J. Natl. Cancer Inst."},{"key":"ref44","doi-asserted-by":"publisher","first-page":"156222","DOI":"10.1016\/j.prp.2025.156222","article-title":"Estrogen receptor conversion in bone, liver and lung metastases from breast cancer","volume":"275","author":"Podany P","year":"2025","unstructured":"Podany, P., Zhan, H., Ai, D., Krishnamurti, U., Liang, Y.: Estrogen receptor conversion in bone, liver and lung metastases from breast cancer. Pathol. - Res. Pract. 275, 156222 (2025). https:\/\/doi.org\/https:\/\/doi.org\/10.1016\/j.prp.2025.156222","journal-title":"Pathol. - Res. Pract."},{"key":"ref45","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1186\/s13058-023-01706-4","article-title":"Receptor conversion and survival in breast cancer liver metastases","volume":"25","author":"Sund\u00e9n M","year":"2023","unstructured":"Sund\u00e9n, M., et al.: Receptor conversion and survival in breast cancer liver metastases. Breast Cancer Res. 25, 105 (2023). https:\/\/doi.org\/10.1186\/s13058-023-01706-4","journal-title":"Breast Cancer Res."},{"key":"ref46","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1016\/j.cell.2006.09.048","article-title":"GATA-3 maintains the differentiation of the luminal cell fate in the mammary gland","volume":"127","author":"Kouros-Mehr H","year":"2006","unstructured":"Kouros-Mehr, H., Slorach, E.M., Sternlicht, M.D., Werb, Z.: GATA-3 maintains the differentiation of the luminal cell fate in the mammary gland. Cell. 127, 1041\u20131055 (2006). https:\/\/doi.org\/10.1016\/j.cell.2006.09.048","journal-title":"Cell"},{"key":"ref47","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1309\/ajcp5mmr1fjvvtpk","article-title":"GATA3 Expression in Advanced Breast Cancer: Prognostic Value and Organ-Specific Relapse","volume":"144","author":"McCleskey BC","year":"2015","unstructured":"McCleskey, B.C., et al.: GATA3 Expression in Advanced Breast Cancer: Prognostic Value and Organ-Specific Relapse. Am. J. Clin. Pathol. 144, 756\u2013763 (2015). https:\/\/doi.org\/10.1309\/ajcp5mmr1fjvvtpk","journal-title":"Am. J. Clin. Pathol."},{"key":"ref48","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1038\/sj.bjc.6601038","article-title":"Prognostic factors for patients with hepatic metastases from breast cancer","volume":"89","author":"Wyld L","year":"2003","unstructured":"Wyld, L., et al.: Prognostic factors for patients with hepatic metastases from breast cancer. Br. J. Cancer. 89, 284\u2013290 (2003). https:\/\/doi.org\/10.1038\/sj.bjc.6601038","journal-title":"Br. J. Cancer"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2024.1386772","article-title":"Vessel co-option: a unique vascular-immune niche in liver cancer","volume":"14\u20132024","author":"Yang D","year":"2024","unstructured":"Yang, D., et al.: Vessel co-option: a unique vascular-immune niche in liver cancer. Front. Oncol. 14\u20132024 (2024). https:\/\/doi.org\/10.3389\/fonc.2024.1386772","journal-title":"Front. Oncol."},{"key":"ref50","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.jhep.2016.07.009","article-title":"Liver sinusoidal endothelial cells: Physiology and role in liver diseases","volume":"66","author":"Poisson J","year":"2017","unstructured":"Poisson, J., et al.: Liver sinusoidal endothelial cells: Physiology and role in liver diseases. J. Hepatol. 66, 212\u2013227 (2017). https:\/\/doi.org\/10.1016\/j.jhep.2016.07.009","journal-title":"J. Hepatol."},{"key":"ref51","doi-asserted-by":"publisher","first-page":"5429","DOI":"10.3748\/wjg.v12.i34.5429","article-title":"Human hepatic sinusoidal endothelial cells can be distinguished by expression of phenotypic markers related to their specialised functions in vivo","volume":"12","author":"Lalor PF","year":"2006","unstructured":"Lalor, P.F., Lai, W.K., Curbishley, S.M., Shetty, S., Adams, D.H.: Human hepatic sinusoidal endothelial cells can be distinguished by expression of phenotypic markers related to their specialised functions in vivo. World J. Gastroenterol. 12, 5429\u20135439 (2006). https:\/\/doi.org\/10.3748\/wjg.v12.i34.5429","journal-title":"World J. Gastroenterol."},{"key":"ref52","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1080\/01913120252959245","article-title":"Ultrastructural localization of laminin and type IV collagen in normal human breast","volume":"26","author":"Fu HL","year":"2002","unstructured":"Fu, H.L., Moss, J., Shore, I., Slade, M.J., Coombes, R.C.: Ultrastructural localization of laminin and type IV collagen in normal human breast. Ultrastruct Pathol. 26, 77\u201380 (2002). https:\/\/doi.org\/10.1080\/01913120252959245","journal-title":"Ultrastruct Pathol."},{"key":"ref53","doi-asserted-by":"publisher","first-page":"3766","DOI":"10.1038\/onc.2011.89","article-title":"Type IV collagen-initiated signals provide survival and growth cues required for liver metastasis","volume":"30","author":"Burnier JV","year":"2011","unstructured":"Burnier, J.V., et al.: Type IV collagen-initiated signals provide survival and growth cues required for liver metastasis. Oncogene. 30, 3766\u20133783 (2011). https:\/\/doi.org\/10.1038\/onc.2011.89","journal-title":"Oncogene"},{"key":"ref54","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s13058-021-01393-z","article-title":"In modern times, how important are breast cancer stage, grade and receptor subtype for survival: a population-based cohort study","volume":"23","author":"Johansson ALV","year":"2021","unstructured":"Johansson, A.L.V., et al.: In modern times, how important are breast cancer stage, grade and receptor subtype for survival: a population-based cohort study. Breast Cancer Res. 23, 17 (2021). https:\/\/doi.org\/10.1186\/s13058-021-01393-z","journal-title":"Breast Cancer Res."},{"key":"ref55","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1093\/jnci\/djx270","article-title":"Intratumor Heterogeneity of the Estrogen Receptor and the Long-term Risk of Fatal Breast Cancer","volume":"110","author":"Lindstr\u00f6m LS","year":"2018","unstructured":"Lindstr\u00f6m, L.S., et al.: Intratumor Heterogeneity of the Estrogen Receptor and the Long-term Risk of Fatal Breast Cancer. J. Natl. Cancer Inst. 110, 726\u2013733 (2018). https:\/\/doi.org\/10.1093\/jnci\/djx270","journal-title":"J. Natl. Cancer Inst."},{"key":"ref56","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1007\/s10555-016-9631-3","article-title":"Estrogen, progesterone, and HER2\/neu receptor discordance between primary and metastatic breast tumours\u2014a review","volume":"35","author":"Yeung C","year":"2016","unstructured":"Yeung, C., et al.: Estrogen, progesterone, and HER2\/neu receptor discordance between primary and metastatic breast tumours\u2014a review. Cancer Metastasis Rev. 35, 427\u2013437 (2016). https:\/\/doi.org\/10.1007\/s10555-016-9631-3","journal-title":"Cancer Metastasis Rev."},{"key":"ref57","doi-asserted-by":"publisher","first-page":"R75","DOI":"10.1186\/bcr2645","article-title":"Receptor conversion in distant breast cancer metastases","volume":"12","author":"Hoefnagel LDC","year":"2010","unstructured":"Hoefnagel, L.D.C., et al.: Receptor conversion in distant breast cancer metastases. Breast Cancer Res. 12, R75 (2010). https:\/\/doi.org\/10.1186\/bcr2645","journal-title":"Breast Cancer Res."},{"key":"ref58","doi-asserted-by":"publisher","first-page":"17588359211012982","DOI":"10.1177\/17588359211012982","article-title":"Receptor conversion impacts outcomes of different molecular subtypes of primary breast cancer","volume":"13","author":"Zhao W","year":"2021","unstructured":"Zhao, W., et al.: Receptor conversion impacts outcomes of different molecular subtypes of primary breast cancer. Therapeutic Adv. Med. Oncol. 13, 17588359211012982 (2021). https:\/\/doi.org\/10.1177\/17588359211012982","journal-title":"Therapeutic Adv. Med. Oncol."},{"key":"ref59","first-page":"1244","article-title":"An estrogen receptor mutant with strong hormone-independent activity from a metastatic breast cancer","volume":"57","author":"Zhang Q-X","year":"1997","unstructured":"Zhang, Q.-X., Borg, \u00c5., Wolf, D.M., Oesterreich, S., Fuqua, S.A.: An estrogen receptor mutant with strong hormone-independent activity from a metastatic breast cancer. Cancer Res. 57, 1244\u20131249 (1997)","journal-title":"Cancer Res."},{"key":"ref60","doi-asserted-by":"publisher","DOI":"10.1210\/endocr\/bqaa050","article-title":"ESR1 Mutations Associated With Estrogen Insensitivity Syndrome Change Conformation of Ligand-Receptor Complex and Altered Transcriptome Profile","volume":"161","author":"Li Y","year":"2020","unstructured":"Li, Y., et al.: ESR1 Mutations Associated With Estrogen Insensitivity Syndrome Change Conformation of Ligand-Receptor Complex and Altered Transcriptome Profile. Endocrinology. 161 (2020). https:\/\/doi.org\/10.1210\/endocr\/bqaa050","journal-title":"Endocrinology"},{"key":"ref61","doi-asserted-by":"publisher","first-page":"7721","DOI":"10.1200\/jco.2005.09.004","article-title":"Biology of progesterone receptor loss in breast cancer and its implications for endocrine therapy","volume":"23","author":"Cui X","year":"2005","unstructured":"Cui, X., Schiff, R., Arpino, G., Osborne, C.K., Lee, A.V.: Biology of progesterone receptor loss in breast cancer and its implications for endocrine therapy. J. Clin. Oncol. 23, 7721\u20137735 (2005). https:\/\/doi.org\/10.1200\/jco.2005.09.004","journal-title":"J. Clin. Oncol."},{"key":"ref62","doi-asserted-by":"publisher","first-page":"6341","DOI":"10.1038\/s41467-021-26505-3","article-title":"Postpartum breast cancer has a distinct molecular profile that predicts poor outcomes","volume":"12","author":"Jindal S","year":"2021","unstructured":"Jindal, S., et al.: Postpartum breast cancer has a distinct molecular profile that predicts poor outcomes. Nat. Commun. 12, 6341 (2021). https:\/\/doi.org\/10.1038\/s41467-021-26505-3","journal-title":"Nat. Commun."},{"key":"ref63","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1016\/s1470-2045(07)70140-7","article-title":"Active versus passive mechanisms in metastasis: do cancer cells crawl into vessels, or are they pushed?","volume":"8","author":"Bockhorn M","year":"2007","unstructured":"Bockhorn, M., Jain, R.K., Munn, L.L.: Active versus passive mechanisms in metastasis: do cancer cells crawl into vessels, or are they pushed? Lancet Oncol. 8, 444\u2013448 (2007). https:\/\/doi.org\/10.1016\/s1470-2045(07)70140-7","journal-title":"Lancet Oncol."},{"key":"ref64","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1007\/s10616-019-00341-2","article-title":"A novel in vitro model of metastasis supporting passive shedding hypothesis from murine pancreatic cancer Panc-02","volume":"71","author":"Krzykawski MP","year":"2019","unstructured":"Krzykawski, M.P., Krzykawska, R., Paw, M., Czyz, J., Marcinkiewicz, J.: A novel in vitro model of metastasis supporting passive shedding hypothesis from murine pancreatic cancer Panc-02. Cytotechnology. 71, 989\u20131002 (2019). https:\/\/doi.org\/10.1007\/s10616-019-00341-2","journal-title":"Cytotechnology"},{"key":"ref65","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1038\/nm.4197","article-title":"Vessel co-option mediates resistance to anti-angiogenic therapy in liver metastases","volume":"22","author":"Frentzas S","year":"2016","unstructured":"Frentzas, S., et al.: Vessel co-option mediates resistance to anti-angiogenic therapy in liver metastases. Nat. Med. 22, 1294\u20131302 (2016). https:\/\/doi.org\/10.1038\/nm.4197","journal-title":"Nat. Med."},{"key":"ref66","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1186\/s12967-015-0425-0","article-title":"Mechanisms involved in breast cancer liver metastasis","volume":"13","author":"Ma R","year":"2015","unstructured":"Ma, R., et al.: Mechanisms involved in breast cancer liver metastasis. J. Translational Med. 13, 64 (2015). https:\/\/doi.org\/10.1186\/s12967-015-0425-0","journal-title":"J. Translational Med."},{"key":"ref67","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1172\/JCI22320","article-title":"Distinct organ-specific metastatic potential of individual breast cancer cells and primary tumors","volume":"115","author":"Minn AJ","year":"2005","unstructured":"Minn, A.J., et al.: Distinct organ-specific metastatic potential of individual breast cancer cells and primary tumors. J. Clin. Investig. 115, 44\u201355 (2005)","journal-title":"J. Clin. Investig."},{"key":"ref68","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines10030667","article-title":"Preclinical Models of Brain Metastases in Breast Cancer","volume":"10","author":"Knier NN","year":"2022","unstructured":"Knier, N.N., Pellizzari, S., Zhou, J., Foster, P.J., Parsyan, A.: Preclinical Models of Brain Metastases in Breast Cancer. Biomedicines. 10 (2022). https:\/\/doi.org\/10.3390\/biomedicines10030667","journal-title":"Biomedicines"},{"key":"ref69","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/bf01606425","article-title":"The hepatic extracellular matrix. I. Components and distribution in normal liver","volume":"423","author":"Martinez-Hernandez A","year":"1993","unstructured":"Martinez-Hernandez, A., Amenta, P.S.: The hepatic extracellular matrix. I. Components and distribution in normal liver. Virchows Arch. Pathol. Anat. Histopathol. 423, 1\u201311 (1993). https:\/\/doi.org\/10.1007\/bf01606425","journal-title":"Virchows Arch. Pathol. Anat. Histopathol"},{"key":"ref70","doi-asserted-by":"publisher","first-page":"2864","DOI":"10.3168\/jds.S0022-0302(03)73883-1","article-title":"Mammary Localization and Abundance of Laminin, Fibronectin, and Collagen IV Proteins in Prepubertal Heifers","volume":"86","author":"Berry SDK","year":"2003","unstructured":"Berry, S.D.K., Howard, R.D., Akers, R.M.: Mammary Localization and Abundance of Laminin, Fibronectin, and Collagen IV Proteins in Prepubertal Heifers. J. Dairy Sci. 86, 2864\u20132874 (2003). https:\/\/doi.org\/https:\/\/doi.org\/10.3168\/jds.S0022-0302(03)73883-1","journal-title":"J. Dairy Sci."},{"key":"ref71","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.addr.2014.01.001","article-title":"The need for complex 3D culture models to unravel novel pathways and identify accurate biomarkers in breast cancer","volume":"69\u201370","author":"Weigelt B","year":"2014","unstructured":"Weigelt, B., Ghajar, C.M., Bissell, M.J.: The need for complex 3D culture models to unravel novel pathways and identify accurate biomarkers in breast cancer. Adv. Drug Deliv Rev. 69\u201370, 42\u201351 (2014). https:\/\/doi.org\/10.1016\/j.addr.2014.01.001","journal-title":"Adv. Drug Deliv Rev."},{"key":"ref72","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1016\/j.ajpath.2025.09.008","article-title":"Inhibiting the Secreted RGDKGE Collagen Peptide Selectively Controls CD8\u2009+\u2009T-Cell Migration on Denatured Collagen-IV and Enhances Their Accumulation in Tumors","volume":"196","author":"Han X","year":"2026","unstructured":"Han, X., Caron, J.M., Brooks, P.C.: Inhibiting the Secreted RGDKGE Collagen Peptide Selectively Controls CD8\u2009+\u2009T-Cell Migration on Denatured Collagen-IV and Enhances Their Accumulation in Tumors. Am. J. Pathol. 196, 598\u2013617 (2026). https:\/\/doi.org\/https:\/\/doi.org\/10.1016\/j.ajpath.2025.09.008","journal-title":"Am. J. Pathol."},{"key":"ref73","doi-asserted-by":"publisher","first-page":"11020","DOI":"10.18632\/oncotarget.24280","article-title":"Selective targeting of collagen IV in the cancer cell microenvironment reduces tumor burden","volume":"9","author":"Revert F","year":"2018","unstructured":"Revert, F., et al.: Selective targeting of collagen IV in the cancer cell microenvironment reduces tumor burden. Oncotarget. 9, 11020\u201311045 (2018). https:\/\/doi.org\/10.18632\/oncotarget.24280","journal-title":"Oncotarget"},{"key":"ref74","doi-asserted-by":"publisher","first-page":"e186997","DOI":"10.1001\/jamanetworkopen.2018.6997","article-title":"Association Between Postpartum Breast Cancer Diagnosis and Metastasis and the Clinical Features Underlying Risk","volume":"2","author":"Goddard ET","year":"2019","unstructured":"Goddard, E.T., et al.: Association Between Postpartum Breast Cancer Diagnosis and Metastasis and the Clinical Features Underlying Risk. JAMA Netw. Open. 2, e186997\u2013e186997 (2019). https:\/\/doi.org\/10.1001\/jamanetworkopen.2018.6997","journal-title":"JAMA Netw. Open."},{"key":"ref75","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1093\/jnci\/djae241","article-title":"Trends in breast cancer-specific death by clinical stage at diagnoses between 2000 and 2017","volume":"117","author":"Marczyk M","year":"2025","unstructured":"Marczyk, M., et al.: Trends in breast cancer-specific death by clinical stage at diagnoses between 2000 and 2017. J. Natl. Cancer Inst. 117, 287\u2013295 (2025). https:\/\/doi.org\/10.1093\/jnci\/djae241","journal-title":"J. Natl. Cancer Inst."},{"key":"ref76","doi-asserted-by":"publisher","DOI":"10.1158\/1538-7445.Sabcs23-po5-25-01","article-title":"Abstract PO5-25-01: Treating liver metastases by reversing cell competition between metastatic cancer cells and hepatocytes","volume":"84","author":"Lake K","year":"2024","unstructured":"Lake, K., et al.: Abstract PO5-25-01: Treating liver metastases by reversing cell competition between metastatic cancer cells and hepatocytes. Cancer Res. 84 (2024). PO5-25-01\u2013PO25-25-01 https:\/\/doi.org\/10.1158\/1538-7445.Sabcs23-po5-25-01","journal-title":"Cancer Res."},{"key":"ref77","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.biocel.2016.10.014","article-title":"Quantitative extracellular matrix proteomics to study mammary and liver tissue microenvironments","volume":"81","author":"Goddard ET","year":"2016","unstructured":"Goddard, E.T., et al.: Quantitative extracellular matrix proteomics to study mammary and liver tissue microenvironments. Int. J. Biochem. Cell Biol. 81, 223\u2013232 (2016). https:\/\/doi.org\/https:\/\/doi.org\/10.1016\/j.biocel.2016.10.014","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"ref78","doi-asserted-by":"publisher","first-page":"13","DOI":"10.3390\/cancers13071698","article-title":"Immune Milieu Established by Postpartum Liver Involution Promotes Breast Cancer Liver Metastasis","author":"Bartlett AQ","year":"2021","unstructured":"Bartlett, A.Q., Pennock, N.D., Klug, A., Schedin, P.: Immune Milieu Established by Postpartum Liver Involution Promotes Breast Cancer Liver Metastasis. Cancers (Basel). 13 (2021). https:\/\/doi.org\/10.3390\/cancers13071698","journal-title":"Cancers (Basel)"},{"key":"ref79","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2420174122","author":"Ozaki MK","year":"2025","unstructured":"Ozaki, M.K., et al.: Reproductive state controls transcription in the murine liver, with implications for breast cancer liver metastasis. Proceedings of the National Academy of Sciences 122, e2420174122 (2025). https:\/\/doi.org\/doi:10.1073\/pnas.2420174122"},{"key":"ref80","doi-asserted-by":"publisher","DOI":"10.1101\/2021.02.18.431862","author":"Bartlett AQ","year":"2021","unstructured":"Bartlett, A.Q., et al.: Pregnancy and weaning regulate human maternal liver size and function. bioRxiv, 2021.2002.2018.431862 (2021). https:\/\/doi.org\/10.1101\/2021.02.18.431862"},{"key":"ref81","doi-asserted-by":"publisher","first-page":"108945","DOI":"10.1016\/j.celrep.2021.108945","article-title":"Single-cell transcriptomics reveals involution mimicry during the specification of the basal breast cancer subtype","volume":"35","author":"Vald\u00e9s-Mora F","year":"2021","unstructured":"Vald\u00e9s-Mora, F., et al.: Single-cell transcriptomics reveals involution mimicry during the specification of the basal breast cancer subtype. Cell. Rep. 35, 108945 (2021). https:\/\/doi.org\/10.1016\/j.celrep.2021.108945","journal-title":"Cell. Rep."},{"key":"ref82","doi-asserted-by":"publisher","first-page":"C1475","DOI":"10.1152\/ajpcell.00189.2022","article-title":"Breast cancers co-opt normal mechanisms of tolerance to promote immune evasion and metastasis","volume":"323","author":"Crump LS","year":"2022","unstructured":"Crump, L.S., Kines, K.T., Richer, J.K., Lyons, T.R.: Breast cancers co-opt normal mechanisms of tolerance to promote immune evasion and metastasis. Am. J. Physiol. Cell. Physiol. 323, C1475\u2013c1495 (2022). https:\/\/doi.org\/10.1152\/ajpcell.00189.2022","journal-title":"Am. J. Physiol. Cell. Physiol."}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/www.researchsquare.com\/article\/rs-9903557\/v1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.researchsquare.com\/article\/rs-9903557\/v1.html","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T08:58:32Z","timestamp":1786006712000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.researchsquare.com\/article\/rs-9903557\/v1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,6]]},"references-count":82,"URL":"https:\/\/doi.org\/10.21203\/rs.3.rs-9903557\/v1","relation":{},"subject":[],"published":{"date-parts":[[2026,8,6]]},"subtype":"preprint"}}